Nebenwirkungen · Bavencio
Bavencio 20 mg/mL concentrate for solution for infusion · Abschnitt 4.8 · PDF-Seite 11
HOS-138024 · Präparat HOS-098135
Frequency Adverse reactions Blood and lymphatic system disorders Very common Anaemia Common Lymphopenia, thrombocytopenia Uncommon Eosinophilia§ Not known Neutropenia* Immune system disorders Very common Infusion-related reaction# Uncommon Hypersensitivity, drug hypersensitivity Rare Anaphylactic reaction, Type I hypersensitivity, sarcoidosis* Endocrine disorders Common Hypothyroidism*, hyperthyroidism* Uncommon Adrenal insufficiency*, autoimmune thyroiditis*, thyroiditis*, autoimmune hypothyroidism* Rare Adrenocortical insufficiency acute*, hypopituitarism* Metabolism and nutrition disorders Very common Decreased appetite Common Hyponatraemia Uncommon Hyperglycaemia* Rare Diabetes mellitus*, Type 1 diabetes mellitus* Nervous system disorders Common Headache, dizziness, neuropathy peripheral Uncommon Myasthenia gravis*,†,ϕ, myasthenic syndrome*,†,ϕ Rare Guillain-Barré Syndrome*, Miller Fisher syndrome* Eye disorders Rare Uveitis* Cardiac disorders Rare Myocarditis*,ϕ Vascular disorders Common Hypertension Uncommon Hypotension, flushing Respiratory, thoracic and mediastinal disorders Very common Cough, dyspnoea Common Pneumonitis* Rare Interstitial lung disease*
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-05-21T17:00:00Z · SHA-256 f560adf7edd288792b6bab7ddc310f7fd91bf0a1dac83f52d792a783eade17a3 · Passage 75ffc820626a0fd643ed26ea5cf1684ee5d66e313e420fc69c53e906dadc335f · Zeichen 1642–3280 im Abschnitt